FDA Approves Fourth COVID Shot. Fifth Shot Considered.
On Mar. 29, 2022, the U.S. Food and Drug Administration (FDA) approved a second booster dose (a fourth shot) of the Pfizer/BioNTech messenger RNA (mRNA) biologic BNT162b2 (“Comirnaty”) and Moderna/NIAID mRNA-1273 (“Spikevax”) for people 50…
CONTINUE READINGVaccinologist Develops Tinnitus After COVID Shot, Calls for More Research
Vaccinologist and director of the Mayo Clinic’s Vaccine Research Group, Gregory M. Poland, MD, who is a leading vaccine developer…
Influenza Vaccine Effectiveness Estimated at 16 Percent
In an interim report published on Mar. 11, 2022, the U.S. Centers for Disease Control and Prevention (CDC) estimates the…
FDA Releases First Set of Pfizer COVID-19 Shot Safety Data
By the end of February 2021, there had been 1,291 reports of adverse events as a result of Pfizer/BioNTech’s experimental…
Harvard Study’s Goal: Identifying Messages That ‘Break Through’ to Vaccine Skeptics
“If only there were a message that could break through skepticism and persuade unvaccinated people to get their shots. What…
Autoimmune Bleeding Disorder Diagnosed After COVID Shots
Four cases of an autoimmune bleeding disorder known as acquired hemophilia (AHA) were diagnosed in Italy’s northern province of Reggio…
NIH-Funded Study Found COVID-19 Shots Impact Menstrual Cycles
A U.S. cohort study assessing the effect of COVID-19 shots on menstrual cycles was peer reviewed and published in the…